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Apreviously healthy 20-year-old woman presented with subacute onset of dyspnea and chestpain. Chest computed tomography scan revealed a contrast-enhanced anterior mediastinalmass (A, arrow) and circumferential pericardial (A, arrowheads) and pleural (A, asterisk)
effusions. Pericardial and pleural fluid analysis ruled out autoimmune or infectious processes. Car-
diac magnetic resonance imaging demonstrated a large cardiac mass with heterogeneous first-pass
contrast-enhanced perfusion with gadolinium (B, arrow) and delayed-enhancement (C), right atrial
invasion (D, arrow, Online Video 1), and large circumferential pericardial (E) effusion. Findings
were suggestive of a highly vascular malignant tumor. Cardiac catheterization showed no right cor-
onary artery involvement but an extensive network of feeding vessels to the mass (F, Online Video 2).
Tumor debulking was attempted but unsuccessful due to the spread throughout the pericar-
dium, right atrium, and atrioventricular groove (G). Cardiac pathological examination revealed
an aggressive high-grade angiosarcoma with sheet-like growth pattern (H); CD31 showed
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.06.071membranous staining in the tumor cells (I). Chemotherapy with paclitaxel was started.
